EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

AksharChem India Limited (AKSHARCHEM) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of AksharChem India Limited ₹158, price ₹394, upside -60.0%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · IN · ISIN INE542B01011

AI Thin data Sep 27, 2026

AksharChem India Limited

AKSHARCHEM · NSE

Structural break: The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.

Weakest SetupStrongly overvalued and low quality.

!Fair value ₹157.72 · Strongly overvalued (−60.0%)
!Quality 46/100
!Expensive Growth (revenue 5y +8.6 %/yr)
!Loss-making · -0.1% net margin (TTM)
!Low debt · negative free cash flow
!0.1% dividend yield · Token dividend
!Trails peers (3/10)
!Narrow moat 25/100
!Evidence only low, so the estimate is less certain
!The models disagree: range ₹51.86 to ₹263.58
!Weak on dividend: 3 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹558.66 ₹145.19 Fair Value ₹157.72 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range ₹145.19 – ₹558.66 · fair‑value band ₹51.86 – ₹263.58 · the ₹394.40 price screens above the ₹157.72 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 27, 2026.

Follow AksharChem India in your weekly email

Every Wednesday you see whether AksharChem India is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

AksharChem (India) Limited manufactures and sells dyes intermediates, pigments, and inorganic chemicals in India. The company offers H-acid, vinyl sulphone, and ortho anicidine and sulpho para vinyl sulphone; reactive blue 21 and black 5 dyes; green 7 pigments; and precipitated silica. It serves textile, ink, paint, and plastic industries.

Show more

AksharChem (India) Limited manufactures and sells dyes intermediates, pigments, and inorganic chemicals in India. The company offers H-acid, vinyl sulphone, and ortho anicidine and sulpho para vinyl sulphone; reactive blue 21 and black 5 dyes; green 7 pigments; and precipitated silica. It serves textile, ink, paint, and plastic industries. The company also exports its products to Europe, the Far East, Southeast Asia, China, the United States, and internationally. The company was formerly known as Audichem (India) Limited and changed its name to AksharChem (India) Limited in March 2003. AksharChem (India) Limited was incorporated in 1989 and is headquartered in Ahmedabad, India.

Stock analysis

AksharChem India Limited (AKSHARCHEM) currently trades at ₹394.40, while our model-based Fair Value estimate is ₹157.72, implying the stock looks roughly 150.1% overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of ₹218.13 per share, and 0 of the 4 models we run sit above the ₹394.40 price.

Bear case: the Multiples group reads lowest at ₹191.62, and 4 of the 4 models stay below the price. Evidence for this calculation is low.

Scenario range: ₹51.86 (bear) to ₹263.58 (bull), the price of ₹394.40 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

AksharChem India Limited reported revenue of ₹3.7B in FY2026 versus ₹3.7B in FY2022, a compound +0.3%/yr. Reported net income was −₹4.4M in FY2026.

Key figures

Market cap ₹3.1B (≈ $32.8M) · P/S ratio 0.52 · EPS (TTM) ₹−0.5500 · Dividend yield 0.1% · Net margin −0.1% · Return on equity −0.2% · Return on assets (EBIT) 3.0% · Operating margin 1.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 15% below its 52-week high and 172% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −54% fair-value upside, at −60%, AKSHARCHEM screens richer than that median.

Fair Value models

Bear ₹51.86 Fair Value ₹157.72 Bull ₹263.58
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Gordon GGM ₹7.69 ₹15.31 ₹23.19 67
DDM Multi-Stage ₹7.69 ₹13.24 ₹16.17 67
EV/EBITDA ₹138.69 ₹191.62 ₹244.55 67
All 4 models by family
Dividend Discount
Gordon GGM ₹7.69 ₹15.31 ₹23.19 67
DDM Multi-Stage ₹7.69 ₹13.24 ₹16.17 67
Multiples
EV/EBITDA ₹138.69 ₹191.62 ₹244.55 67
Asset-Based
NCAV (Graham) ₹162.78 ₹218.13 ₹325.56 54

Open the full fair value analysis →

Notify me when AKSHARCHEM reaches fair value

Put AKSHARCHEM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 46/100

Of which business quality 46 · Market factors (momentum, volatility) 81

Profitability 26
Margins and returns on capital today
Quality Growth 30
Are margins and returns improving?
Cashflow 37
Earnings quality: real cash, not paper profit
Fin. Strength 43
Balance sheet, leverage, solvency risk
Investment 74
Disciplined investing over empire-building
Low Volatility 62
Calm price path (market factor)
Momentum 92
Price trend over the last 3–12 months (market factor)
52W Momentum 83
Distance to the 52-week high (market factor)
Net Issuance 86
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
Start year 2021 (pandemic). Over 10 years: +7.1% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.6% (2021) → 0.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

AKSHARCHEM screens 150% overvalued. Compare with Linde plc →

Compare AksharChem India Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 706 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −60.0% · Bottom 25%
Profitability
Return on assets 0.1% · Bottom 25%
Net margin (TTM) −0.1% · Bottom 25%
Operating margin (TTM) 1.0% · Bottom 25%
Growth and dividend
Revenue growth 16.6% · Above median
Dividend yield (TTM) 0.1% · Bottom 25%
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

EV/EBITDA 1.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)83 · sector 26
PAST (return on equity)0 · sector 23
HEALTH (low debt)97 · sector 95
DIVIDEND (yield)3 · sector 29

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $469.89 $441.72 −6%
The Sherwin-Williams Company SHW $329.10 $151.68 −54%
Ecolab Inc ECL $279.49 $96.56 −65%
Air Products and Chemicals, Inc APD $281.76 $121.30 −57%
Givaudan SA GIVN CHF 3,447 CHF 1,527 −56%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%
PPG Industries, Inc PPG $107.52 $76.98 −28%
EMS-CHEMIE HOLDING AG EMSN CHF 820.50 CHF 284.63 −65%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "AksharChem India Limited Fair Value". https://www.fairvalue-calculator.com/stock/AKSHARCHEM

Frequently asked questions

Is AksharChem India Limited (AKSHARCHEM) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹157.72 versus a price of ₹394.40, about −60% upside (overvalued).
What is the fair value of AKSHARCHEM?
Our model-based fair value for AksharChem India Limited is ₹157.72 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹394.40.
What is the quality score of AKSHARCHEM?
AksharChem India Limited has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for AksharChem India Limited (AKSHARCHEM)?
Our model-based price target is the fair value of ₹157.72 (as of Sep 27, 2026) from 4 valuation models. Cautious scenario ₹51.86, optimistic scenario ₹263.58. It is a calculation from audited fundamentals, not an analyst target.
What is the AksharChem India Limited stock forecast for 2026?
Our models put fair value at ₹157.72, about −60% upside versus a price of ₹394.40 (overvalued). Cautious scenario ₹51.86, optimistic scenario ₹263.58. The calculation is refreshed regularly with new filings.
What is the revenue of AksharChem India Limited (AKSHARCHEM)?
AksharChem India Limited reported trailing-twelve-month revenue of about ₹3.7B (latest available figure, as of Sep 27, 2026).
Does AksharChem India Limited pay a dividend?
AksharChem India Limited currently shows a dividend yield of about 0.13% relative to its recent price (as of Sep 27, 2026).
What is the intrinsic value of AksharChem India Limited (AKSHARCHEM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For AksharChem India Limited it is ₹157.72 per share (as of Sep 27, 2026), against a price of ₹394.40. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is AksharChem India Limited stock overvalued or undervalued in 2026?
As of Sep 27, 2026, AKSHARCHEM trades above its calculated fair value: price ₹394.40, fair value ₹157.72, a gap of about −60% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AKSHARCHEM?
No. The price is what the market pays today (₹394.40); the fair value is what the company's own numbers justify (₹157.72). For AksharChem India Limited the two are ₹236.68 per share apart. That gap is exactly why we show both numbers side by side.
How much is AksharChem India Limited worth?
The market values AksharChem India Limited at about ₹3.1B (market capitalisation, as of Sep 27, 2026). Per share that is ₹394.40; our models calculate a fair value of ₹157.72 per share.
What do the bullish and bearish scenarios say about AKSHARCHEM?
Our models span a range for AksharChem India Limited: cautious scenario ₹51.86, base ₹157.72, optimistic ₹263.58 per share (as of Sep 27, 2026, price ₹394.40). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of AksharChem India Limited (AKSHARCHEM)?
Balance-sheet figures for AksharChem India Limited (as of Sep 27, 2026): return on equity −0.2%, debt of 0.07 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is AKSHARCHEM from its 52-week high?
AksharChem India Limited trades at ₹394.40, about 15% below its 52-week high of ₹463.90 and 172% above the low of ₹145.19 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of ₹157.72 is for.
Which stocks are comparable to AksharChem India Limited?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is AksharChem India Limited stock attractive at the current price?
The data as of Sep 27, 2026: price ₹394.40, calculated fair value ₹157.72 (−60%), Quality Score 46/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AKSHARCHEM calculated?
We run AksharChem India Limited through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹157.72, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. AksharChem India Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of AksharChem India Limited (AKSHARCHEM)?
The closing price on Sep 25, 2026 was ₹394.40. Our model-based fair value is ₹157.72, about −60% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with AksharChem India Limited right now?
The price sits above even our optimistic bull case (₹263.58). The favourable scenario is already priced in. The model range is unusually wide (₹51.86 to ₹263.58). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of AksharChem India Limited

How large is the market capitalisation of AksharChem India Limited (AKSHARCHEM)?
The market capitalisation of AksharChem India Limited is ₹3.1B (≈ $32.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of AksharChem India Limited (AKSHARCHEM)?
The price-to-sales ratio of AksharChem India Limited is 0.52 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of AksharChem India Limited (AKSHARCHEM)?
Earnings per share at AksharChem India Limited are ₹−0.5500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of AksharChem India Limited (AKSHARCHEM)?
The dividend yield of AksharChem India Limited is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of AksharChem India Limited (AKSHARCHEM)?
The net margin of AksharChem India Limited is −0.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of AksharChem India Limited (AKSHARCHEM)?
The return on equity (ROE) of AksharChem India Limited is −0.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of AksharChem India Limited (AKSHARCHEM)?
On an EBIT basis the return on assets of AksharChem India Limited is 3.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of AksharChem India Limited (AKSHARCHEM)?
The operating margin of AksharChem India Limited is 1.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at AksharChem India Limited (AKSHARCHEM)?
Revenue at AksharChem India Limited is growing +16.6% versus a year earlier (3y avg +3.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at AksharChem India Limited (AKSHARCHEM)?
Earnings per share at AksharChem India Limited are growing +248% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does AksharChem India Limited (AKSHARCHEM) generate?
The free cash flow of AksharChem India Limited is −₹410M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does AksharChem India Limited (AKSHARCHEM) carry?
The net debt of AksharChem India Limited is ₹1.1B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch AksharChem India Limited in the live analysis

One click puts AksharChem India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.